| |
Etonogestrel subdermal implant for the management of endometriosis-associated pain after ovarian-sparing surgery
. . . |
Pending |
30 Nov -0001 |
| |
EffectiveNess of VISanne® in Improving Quality of Life in asIan wOmen With eNdometriosis
|
Ongoing |
14 Jun 2018 |
| |
Narrowband ultraviolet B phototherapy versus visible light in HIV pruritus: a randomized controlled trial
. . . |
Ongoing |
04 Oct 2017 |
| | A Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Dose and Multiple Doses of GSK3389404 in Chronic Hepatitis B Subj . . . |
Ongoing |
18 Jan 2018 |
| | Phase 3, Randomized, double-blind, placebo-controlled, 26 week multicenter study to evaluate the efficacy and safety of Ertugliflozin in Asian Subjects with Type 2 Diabetes Mellitus and inadequate gly . . . |
Ongoing |
17 Dec 2018 |
| |
A Phase 3 Randomized, Double-Blind Study Assessing the Efficacy and Safety of PF-06438179 and Infliximab in Combination with Methotrexate in Subjects with Moderately to Severely Active Rheumatoid Art . . . |
Completed |
18 Dec 2018 |
| | The impact of speech and lip reading training and adjustment counseling on the elderly individual’s ability to cope with mild sensorineural hearing loss . . . |
Completed |
12 Feb 2016 |
| | An Observational Study on the Effects of Ballroom Dancing Filipino Elderly with Mild Cognitive Impairment . . . |
Ongoing |
12 Feb 2016 |
| | Burden of Alzheimer’s Disease among Community Dwelling Filipino Community |
Ongoing |
12 Feb 2016 |
| |
GlobalSurg-CovidSurg Week: Determining the optimal timing for surgery following SARS-CoV-2 infection – Philippine General Hospital data
. . . |
Completed |
24 May 2022 |
| |
Glucoacetobacter Xylinus-derived Cellulose Gel in the Prevention of Radiation Therapy-Induced High-Grade Acute Dermatitis among Filipino Patients with Breast Cancer: A Pilot Randomized Control . . . |
Ongoing |
30 Nov -0001 |
| |
Public health emergency SOLIDARITY TRIAL
|
Ongoing |
20 May 2020 |
| | PHASE 1,STUDY TO ASSESS THE PHARMACOKINETICS, SAFETY AND TOLERABILITY OF CEFTAZIDIMEAVIBACTAM (CAZ-AVI) IN CHILDREN FROM 3 MONTHS TO LESS THAN 18 YEARS OF AGE WHO ARE HOSPITALIZED AND RECEIVING SYSTE . . . |
Ongoing |
17 Aug 2021 |
| |
A multi-center, randomized, 12-week treatment, doubleblind study to assess the efficacy and safety of QMF149 (150/80 microgram) compared with MF Twisthaler® (200 microgram) in adult and adolesce . . . |
Completed |
03 Mar 2020 |
| | Afatinib as second line therapy for lung cancer with Epidermal Growth Factor Receptor mutation. |
Completed |
29 Nov 2018 |
| | A randomized, double-blind, placebo-controlled, phase III study evaluating the efficacy and safety of pembrolizumab plus platinum-based doublet chemotherapy with or without canakinumab as first lin . . . |
Ongoing |
20 May 2021 |
| | A Randomized, Observer-blind, Placebo-controlled, Multicenter, Phase 3 Study to Assess the Efficacy, Safety, and Immunogenicity of a Plant-Derived Quadrivalent VLP Influenza Vaccine in Adults 18-64 . . . |
Completed |
15 Oct 2018 |
| | A study to determine the safety and immunogenicity of a new Pneumococcal vaccine in healthy infants |
Completed |
17 Aug 2021 |
| | A Two-Arm, Open-label, Randomized Phase III Study of Pembrolizumab (MK-3475) Monotherapy versus Standard Chemotherapy in Platinum Pre-treated, Recurrent or Metastatic Nasopharyngeal Cancer (NPC) (K . . . |
Ongoing |
27 Jul 2022 |
| | An open-label, multicenter, Phase IIIb study to assess the safety and efficacy of ribociclib (LEE011) in combination with letrozole for the treatment of men and pre/postmenopausal women with hormone . . . |
Ongoing |
03 Feb 2022 |
| | Immunogenicity, reactogenicity and safety of a booster dose of MenACWY-TT vaccine (PF-06866681). |
Ongoing |
21 Jul 2017 |
| | Imovax® Rabies and VERORAB® Immunogenicity and Safety after One Week 2-sites Intradermal or 1-site Intramuscular Pre-Exposure Prophylaxis Regimens, Followed by a Simulated Intradermal or Intramusc . . . |
Completed |
14 Sep 2022 |
| | Methotrexate Withdrawal Study of Tofacitinib Modified Release Formulation in Subjects With Rheumatoid Arthritis
. . . |
Completed |
19 Mar 2019 |
| | Reduced-dosed rivaroxaban in the long-term prevention of recurrent symptomatic VTE |
Completed |
28 Dec 2021 |
| | Safety of Plasma Aβ1-42 and Aβ1-40 Reduction with H.E.A.L.E.R (Haemoadsorption for Extracorporeal Amyloid-β Level Expedited Reduction) using BETACLEAR BICARB 1000 in Healthy Elderly Individuals . . . |
Pending |
04 Feb 2015 |